Moderna logo and stock graph are seen displayed in this illustration taken, May 3, 2022. Reuters-Yonhap
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo.
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
Richard Hatchett, head of CEPI, told Reuters it was possible to get vaccines against Ebola Bundibugyo ready for trials within a couple of months.
There are no approved vaccines or treatments for Ebola Bundibugyo.
